Novartis AG (NYSE:NVS) was downgraded by Leerink Swann from an “outperform” rating to a “market perform” rating in a report released on Wednesday, The Fly reports.
Other research analysts also recently issued research reports about the stock. Vetr downgraded shares of Novartis AG from a “strong-buy” rating to a “buy” rating and set a $82.82 price objective on the stock. in a research report on Monday, March 14th. JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Novartis AG in a research report on Monday, January 25th. Zacks Investment Research raised shares of Novartis AG from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research report on Tuesday, December 29th. TheStreet downgraded shares of Novartis AG from a “buy” rating to a “hold” rating in a research report on Friday, January 29th. Finally, Goldman Sachs lifted their target price on shares of Novartis AG from $89.00 to $92.00 and gave the stock a “neutral” rating in a research note on Thursday, January 7th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $94.36.
Shares of Novartis AG (NYSE:NVS) opened at 74.39 on Wednesday. Novartis AG has a 1-year low of $70.64 and a 1-year high of $106.84. The company’s 50-day moving average is $73.30 and its 200 day moving average is $84.35. The company has a market cap of $176.59 billion and a price-to-earnings ratio of 10.20.
Source: American Banking and Market News